New Test For the Diagnosis of Active Lyme

There is a new test that was announced last week that is being released here in the US called the (LTT-MELISA) for Lyme borreliosis. This test was created in Germany with testing here through IGENEX. There is promise that this test can give better accuracy than the current CD57 in diagnosing an active infection of Lyme. This would also be wonderful for people that have already had long term treatment and still have low CD57's. Some people may always have a low CD57 but this test shows promise in better understanding the activity of this disease. MELISA® Medica Foundation (LTT-MELISA)